Table 2.
Comparison of nitrates, nicorandil and molsidomine
| Long-acting nitrates | Nicorandil | Molsidomine | |
|---|---|---|---|
| Evidence for benefit in stable angina | Yes | Yes | Yes [102–104] |
| Randomised evidence | Yes [105] | Yes | Yes [104] |
| Comparison against placebo | Yes [105] | Yes | Yes [104] |
| Benefit as add-on to first line therapy | Yes, although poor-quality evidence [37] | Yes | Yes |
| Benefit in microvascular dysfunction | No [106, 107] | Yes, but limited evidence | No evidence |
| Concerns about tolerance and endothelial dysfunction | Yes | No | Evidence unclear [102, 108] |
| Cost for 28 days treatment [109] | Isosorbide mononitrate 25 mg modified-release capsules; NHS prescription price: £9 | Nicorandil (20 mg twice a day); NHS prescription price: £9 | Molsidomine tablets (2 mg); NHS prescription price: £9.00 |
| Isosorbide mononitrate MR tablets (60 mg); Basic NHS price: £10.50 | Nicorandil (20 mg twice a day); Basic NHS price: £4.59 | ||
| Isosorbide dinitrate (20 mg four times a day): £29.04 | Nicorandil (10 mg; 30 tablets): 30 Saudi Riyal | ||
| Isosorbide dinitrate (10 mg; 30 tablets): 25 Saudi Riyal; (20 mg; 30 tablets): 45 Saudi Riyal | Nicorandil (20 mg; 30 tablets): 60 Saudi Riyal |